US Stock MarketDetailed Quotes

TLIS Talis Biomedical

Watchlist

1.850
+0.100+5.71%

15min DelayClose Nov 27 16:00 ET

3.37MMarket Cap-66P/E (TTM)

Talis Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

20.62%-11.33M

60.97%-6.43M

46.83%-53.24M

16.14%-11.36M

46.48%-11.14M

35.16%-14.27M

62.37%-16.47M

41.57%-100.14M

66.76%-13.54M

72.14%-20.82M

Net income from continuing operations

41.14%-8.85M

26.90%-13.04M

45.13%-62.01M

50.02%-13.46M

39.73%-15.68M

44.34%-15.03M

46.05%-17.83M

41.15%-113.01M

6.02%-26.93M

32.27%-26.02M

Depreciation and amortization

-50.00%84K

50.57%262K

-91.28%770K

-94.08%211K

-94.47%217K

-82.86%168K

-52.07%174K

459.57%8.83M

280.15%3.56M

1,599.13%3.93M

Other non cash items

-90.77%247K

-48.66%403K

55.32%4.3M

-50.73%403K

-53.33%441K

346.58%2.68M

91.93%785K

165.68%2.77M

2,626.67%818K

94.85%945K

Change In working capital

-46.82%-4.64M

147.81%371K

55.45%-3.42M

-88.65%469K

104.34%42K

-245.31%-3.16M

94.04%-776K

-187.10%-7.69M

125.47%4.13M

97.55%-967K

-Change in receivables

101.72%7K

-76.37%43K

307.20%259K

-136.00%-45K

160.10%528K

-120.67%-406K

107.53%182K

-143.40%-125K

247.22%125K

299.02%203K

-Change in inventory

----

--192K

-Change in prepaid assets

-297.81%-2.91M

-94.11%76K

211.09%1.88M

-53.52%628K

-56.89%691K

-152.29%-731K

134.45%1.29M

-94.85%604K

288.22%1.35M

-15.85%1.6M

-Change in payables and accrued expense

14.09%-1.74M

111.20%252K

37.55%-5.56M

-447.45%-2.18M

130.09%891K

10.17%-2.02M

47.96%-2.25M

-468.32%-8.91M

105.05%628K

92.82%-2.96M

-Change in other current assets

----

--0

----

--741K

---239K

--0

-Change in other current liabilities

----

96.40%-4K

Cash from discontinued investing activities

Operating cash flow

20.62%-11.33M

60.97%-6.43M

46.83%-53.24M

16.14%-11.36M

46.48%-11.14M

35.16%-14.27M

62.37%-16.47M

41.57%-100.14M

66.76%-13.54M

72.14%-20.82M

Investing cash flow

Cash flow from continuing investing activities

117.32%84K

225.00%30K

69.91%-486K

289.80%93K

91.86%-70K

-143.72%-485K

95.27%-24K

43.65%-1.62M

95.04%-49K

-13.31%-860K

Net PPE purchase and sale

117.32%84K

225.00%30K

69.91%-486K

289.80%93K

91.86%-70K

-143.72%-485K

95.27%-24K

43.65%-1.62M

95.04%-49K

-13.31%-860K

Cash from discontinued investing activities

Investing cash flow

117.32%84K

225.00%30K

69.91%-486K

289.80%93K

91.86%-70K

-143.72%-485K

95.27%-24K

43.65%-1.62M

95.04%-49K

-13.31%-860K

Financing cash flow

Cash flow from continuing financing activities

-93.94%2K

-91.87%33K

-89.49%33K

-99.83%406K

-90.82%92K

Proceeds from stock option exercised by employees

--0

-93.94%2K

-91.87%33K

--0

-89.49%33K

-78.44%406K

--0

-90.82%92K

Cash from discontinued financing activities

Financing cash flow

--0

-93.94%2K

-91.87%33K

--0

-89.49%33K

-99.83%406K

--0

-90.82%92K

Net cash flow

Beginning cash position

-37.77%71.88M

-40.69%78.27M

-43.44%131.97M

-38.49%89.54M

-39.72%100.75M

-39.00%115.51M

-43.44%131.97M

34.76%233.31M

-46.95%145.56M

-52.09%167.15M

Current changes in cash

23.80%-11.25M

61.14%-6.4M

47.02%-53.69M

17.13%-11.26M

48.06%-11.21M

33.55%-14.76M

62.56%-16.46M

-268.41%-101.35M

66.90%-13.59M

71.02%-21.59M

End cash Position

-39.82%60.63M

-37.77%71.88M

-40.69%78.27M

-38.49%89.54M

-39.72%100.75M

-39.00%115.51M

-43.44%131.97M

-46.95%145.56M

Free cash flow

23.23%-11.33M

61.02%-6.43M

47.20%-53.73M

17.13%-11.26M

48.28%-11.21M

33.55%-14.76M

62.75%-16.49M

41.61%-101.75M

67.43%-13.59M

71.28%-21.68M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	20.62%-11.33M	60.97%-6.43M	46.83%-53.24M	16.14%-11.36M	46.48%-11.14M	35.16%-14.27M	62.37%-16.47M	41.57%-100.14M	66.76%-13.54M	72.14%-20.82M
Net income from continuing operations	41.14%-8.85M	26.90%-13.04M	45.13%-62.01M	50.02%-13.46M	39.73%-15.68M	44.34%-15.03M	46.05%-17.83M	41.15%-113.01M	6.02%-26.93M	32.27%-26.02M
Depreciation and amortization	-50.00%84K	50.57%262K	-91.28%770K	-94.08%211K	-94.47%217K	-82.86%168K	-52.07%174K	459.57%8.83M	280.15%3.56M	1,599.13%3.93M
Other non cash items	-90.77%247K	-48.66%403K	55.32%4.3M	-50.73%403K	-53.33%441K	346.58%2.68M	91.93%785K	165.68%2.77M	2,626.67%818K	94.85%945K
Change In working capital	-46.82%-4.64M	147.81%371K	55.45%-3.42M	-88.65%469K	104.34%42K	-245.31%-3.16M	94.04%-776K	-187.10%-7.69M	125.47%4.13M	97.55%-967K
-Change in receivables	101.72%7K	-76.37%43K	307.20%259K	-136.00%-45K	160.10%528K	-120.67%-406K	107.53%182K	-143.40%-125K	247.22%125K	299.02%203K
-Change in inventory	----	----	----	----	----	----	----	----	----	--192K
-Change in prepaid assets	-297.81%-2.91M	-94.11%76K	211.09%1.88M	-53.52%628K	-56.89%691K	-152.29%-731K	134.45%1.29M	-94.85%604K	288.22%1.35M	-15.85%1.6M
-Change in payables and accrued expense	14.09%-1.74M	111.20%252K	37.55%-5.56M	-447.45%-2.18M	130.09%891K	10.17%-2.02M	47.96%-2.25M	-468.32%-8.91M	105.05%628K	92.82%-2.96M
-Change in other current assets	----	----	--0	--0	----	----	----	--741K	---239K	--0
-Change in other current liabilities	----	----	----	----	----	----	----	----	----	96.40%-4K
Cash from discontinued investing activities
Operating cash flow	20.62%-11.33M	60.97%-6.43M	46.83%-53.24M	16.14%-11.36M	46.48%-11.14M	35.16%-14.27M	62.37%-16.47M	41.57%-100.14M	66.76%-13.54M	72.14%-20.82M
Investing cash flow
Cash flow from continuing investing activities	117.32%84K	225.00%30K	69.91%-486K	289.80%93K	91.86%-70K	-143.72%-485K	95.27%-24K	43.65%-1.62M	95.04%-49K	-13.31%-860K
Net PPE purchase and sale	117.32%84K	225.00%30K	69.91%-486K	289.80%93K	91.86%-70K	-143.72%-485K	95.27%-24K	43.65%-1.62M	95.04%-49K	-13.31%-860K
Cash from discontinued investing activities
Investing cash flow	117.32%84K	225.00%30K	69.91%-486K	289.80%93K	91.86%-70K	-143.72%-485K	95.27%-24K	43.65%-1.62M	95.04%-49K	-13.31%-860K
Financing cash flow
Cash flow from continuing financing activities	0	-93.94%2K	-91.87%33K	0	0	0	-89.49%33K	-99.83%406K	0	-90.82%92K
Proceeds from stock option exercised by employees	--0	-93.94%2K	-91.87%33K	--0	--0	--0	-89.49%33K	-78.44%406K	--0	-90.82%92K
Cash from discontinued financing activities
Financing cash flow	--0	-93.94%2K	-91.87%33K	--0	--0	--0	-89.49%33K	-99.83%406K	--0	-90.82%92K
Net cash flow
Beginning cash position	-37.77%71.88M	-40.69%78.27M	-43.44%131.97M	-38.49%89.54M	-39.72%100.75M	-39.00%115.51M	-43.44%131.97M	34.76%233.31M	-46.95%145.56M	-52.09%167.15M
Current changes in cash	23.80%-11.25M	61.14%-6.4M	47.02%-53.69M	17.13%-11.26M	48.06%-11.21M	33.55%-14.76M	62.56%-16.46M	-268.41%-101.35M	66.90%-13.59M	71.02%-21.59M
End cash Position	-39.82%60.63M	-37.77%71.88M	-40.69%78.27M	-40.69%78.27M	-38.49%89.54M	-39.72%100.75M	-39.00%115.51M	-43.44%131.97M	-43.44%131.97M	-46.95%145.56M
Free cash flow	23.23%-11.33M	61.02%-6.43M	47.20%-53.73M	17.13%-11.26M	48.28%-11.21M	33.55%-14.76M	62.75%-16.49M	41.61%-101.75M	67.43%-13.59M	71.28%-21.68M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data